# Bioventus Inc. (BVS) — divestiture/asset_sale [announced]
Source: SEC API (secapi.ai) · situation sit_67b40f2fe3cc25023929 · retrieved 2026-08-12T06:58:35.830Z

## Overview
Bioventus Inc. is a global leader in innovations for active healing, delivering clinically proven, cost-effective products for pain treatments, surgical solutions, and restorative therapies.

Bioventus Inc. announced on August 5, 2026, that its Board of Directors has established a committee of independent directors to evaluate strategic alternatives following receipt of an unsolicited acquisition proposal and multiple other expressions of interest. The committee, with assistance from Evercore as financial advisor and Latham & Watkins as legal counsel, is evaluating a range of options including a potential sale of the company or continued execution of the company's standalone plan, with the goal of maximizing shareholder value. The company has not set a timetable for completion of the review and stated there is no assurance the process will result in any transaction.

## Key dates
- Announced 2026-08-05

## Timeline
- 2026-08-05 · 8-K (0001665988-26-000041): 8-K - Bioventus Inc. — *Bioventus Inc. is a global leader in innovations for active healing, delivering clinically proven, cost-effective products for pain treatments, surgical solutions, and restorative therapies.* Bioventus Inc. announced on August 5, 2026, that its Board of Directors has established a committee of independent directors to evaluate strategic alternatives following receipt of an unsolicited acquisition proposal and multiple other expressions of interest. The committee, with assistance from Evercore as financial advisor and Latham & Watkins as legal counsel, is evaluating a range of options including a potential sale of the company or continued execution of the company's standalone plan, with the goal of maximizing shareholder value. The company has not set a timetable for completion of the review and stated there is no assurance the process will result in any transaction.
  https://www.sec.gov/Archives/edgar/data/1665988/0001665988-26-000041.txt

## Citations
- 0001665988-26-000041 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000166598826000041